Aviragen Therapeutics (AVIR) Tops Q2 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: AVIR) | Delayed: 4.33 +0.16 (3.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.17 | 52 Week High | $2.00 | |||
| Open | $4.29 | 52 Week Low | $1.15 | |||
| Day High | $4.40 | P/E | N/A | |||
| Day Low | $4.29 | EPS | $0.00 | |||
| Volume | 14,078 | |||||
